Novartis AG ADR [NVS] stock is trading at $126.82, down -0.34%. An important factor to consider is whether the stock is rising or falling in short-term value. The NVS shares have gain 3.87% over the last week, with a monthly amount glided 7.50%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Novartis AG ADR [NYSE: NVS] stock has seen the most recent analyst activity on August 08, 2025, when Morgan Stanley upgraded its rating to a Equal-Weight but kept the price target unchanged to $123 for it. Previously, UBS downgraded its rating to Neutral on February 13, 2025. On February 12, 2025, Morgan Stanley initiated with a Underweight rating. Deutsche Bank upgraded its rating to a Buy. HSBC Securities downgraded its rating to a Reduce. BofA Securities downgraded its rating to Neutral for this stock on September 11, 2024, and downed its price target to $130. In a note dated September 05, 2024, Goldman downgraded an Neutral rating on this stock.
Novartis AG ADR [NVS] stock has fluctuated between $96.06 and $127.68 over the past year. Currently, Wall Street analysts expect the stock to reach $116.33 within the next 12 months. Novartis AG ADR [NYSE: NVS] shares were valued at $126.82 at the most recent close of the market. An investor can expect a potential drop of -8.27% based on the average NVS price forecast.
Analyzing the NVS fundamentals
Novartis AG ADR [NYSE:NVS] reported sales of 53.55B for the trailing twelve months, which represents a growth of 14.31%. Gross Profit Margin for this corporation currently stands at 0.76% with Operating Profit Margin at 0.3%, Pretax Profit Margin comes in at 0.28%, and Net Profit Margin reading is 0.25%. To continue investigating profitability, this company’s Return on Assets is posted at 0.13, Equity is 0.33 and Total Capital is 0.23. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.78.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 126.44 points at the first support level, and at 126.07 for the second support level. However, for the 1st resistance point, the stock is sitting at 127.33, and for the 2nd resistance point, it is at 127.85.
Ratios To Look Out For
For context, Novartis AG ADR’s Current Ratio is 0.82. On the other hand, the Quick Ratio is 0.62, and the Cash Ratio is 0.21. Considering the valuation of this stock, the price to sales ratio is 4.49, the price to book ratio is 5.85 and price to earnings (TTM) ratio is 18.37.
Transactions by insiders
Recent insider trading involved Marshall Fiona, Officer, that happened on May 23 ’25 when 15000.0 shares were purchased. Officer, Kowalski Robert William completed a deal on Apr 30 ’25 to buy 1212.0 shares.
